Neoplasms, Unknown Primary

2 treatments and conditions followed through the public trial records. Not medical advice.How a status is set

Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.

Treatments and conditions

Neoplasms, Unknown Primary
Treatment and conditionWhere it standsTrials
Spartalizumab for neoplasms, unknown primaryPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tislelizumab for neoplasms, unknown primaryPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1